Connect with us

Librium (chlordiazepoxide)


Chlordiazepoxide (or LIBRIUM®) is mainly prescribed to treat anxiety disorders, insomnia, and alcohol withdrawal syndrome.

Status: ACTIVE

Class: Benzodiazepine

FDA Approval: 1960

Dosage Forms: 5 mg, 10 mg, 25 mg

Biological Half-life: 5-30 hours

Side Effects: Dizziness, sleepiness, blurred vision, poor concentration, amnesia, ataxia, confusion, constipation, nausea, skin rash

Routes of Administration: Oral, IM

Pregnancy Category: D (US)

  www.fda.gov

Advertisement

© 2018 Mental Daily. All Rights Reserved.
Our content is for informational purposes and should not be used as medical or treatment recommendation.